ENTA
Enanta Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$405.64M
P/E Ratio
—
EPS
$-2.60
Beta
1.01
52W High
$17.15
52W Low
$5.70
50-Day MA
$13.61
200-Day MA
$12.33
Dividend Yield
—
Profit Margin
-89.60%
Forward P/E
44.05
PEG Ratio
0.00
About Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | $69.21M |
| Gross Profit (TTM) | $69.21M |
| EBITDA | $-55.45M |
| Operating Margin | -69.10% |
| Return on Equity | -59.00% |
| Return on Assets | -11.80% |
| Revenue/Share (TTM) | $2.75 |
| Book Value | $4.36 |
| Price-to-Book | 3.48 |
| Price-to-Sales (TTM) | 5.86 |
| EV/Revenue | 4.311 |
| EV/EBITDA | 41.13 |
| Quarterly Earnings Growth (YoY) | -66.20% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $29.08M |
| Float | $20.06M |
| % Insiders | 4.68% |
| % Institutions | 92.80% |
Historical Volatility
HV 10-Day
42.09%
HV 20-Day
40.74%
HV 30-Day
40.82%
HV 60-Day
48.09%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($20.14 target)
1
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026